1. 134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study. (April 2020) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Forrest Gordon, Mark; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study. (April 2020) Authors: Fernandez, Hubert H.; Barkay, Hadas; Hauser, Robert A.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 25:Number 2(2020) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase II study of laquinimod in Crohn's disease. Issue 8 (3rd October 2014) Authors: D'Haens, Geert; Sandborn, William J; Colombel, Jean Frederic; Rutgeerts, Paul; Brown, Kurt; Barkay, Hadas; Sakov, Anat; Haviv, Asi; Feagan, Brian G Other Names: author non-byline.; Baert Filip author non-byline.; Dupas Jean-Louis author non-byline.; Bouhnik Yoram author non-byline.; Bonaz Bruno author non-byline.; Hebuterne Xavier author non-byline.; Allez Matthieu author non-byline.; Israeli Eran author non-byline.; Fraser Gerald author non-byline.; Se... Journal: Gut Issue: Volume 64:Issue 8(2015) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the Pharmacokinetics, Pharmacodynamics, and Safety of Single Doses of TV‐1106, a Long‐Acting Growth Hormone, in Healthy Japanese and Caucasian Subjects. Issue 4 (21st September 2016) Authors: Cohen‐Barak, Orit; Barkay, Hadas; Rasamoelisolo, Michele; Butler, Kathleen; Yamada, Kazumasa; Bassan, Merav; Yoon, Esther; Spiegelstein, Ofer Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 4(2017) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients with Tardive Dyskinesia. (April 2021) Authors: Wilhelm, Amanda; Anderson, Karen E.; Fernandez, Hubert H.; Barkay, Hadas; Chaijale, Nayla; Send, Alexander F.; Savola, Juha-Matti; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Deutetrabenazine Reduces Severe Tardive Dyskinesia Movements in a 3-year Open-Label Extension Trial. (April 2021) Authors: Chaijale, Nayla; Bona, Joseph; Barkay, Hadas; Wilhelm, Amanda; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose Patterns for Long-Term Deutetrabenazine Treatment in Patients With Tardive Dyskinesia by Baseline AIMS Item 8 Score. (April 2022) Authors: Barkay, Hadas; Finkbeiner, Stacy; Wilhelm, Amanda; Alexander, Jessica; Chaijale, Nayla; Gordon, Mark Forrest Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia. (April 2021) Authors: Jimenez-Shahed, Joohi; Barkay, Hadas; Anderson, Karen E.; Fernandez, Hubert H.; Factor, Stewart A.; Hauser, Robert A.; Wieman, Maria; Gordon, Mark Forrest; Savola, Juha-Matti Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders. (April 2022) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study. (April 2021) Authors: Hauser, Robert A.; Barkay, Hadas; Fernandez, Hubert H.; Factor, Stewart A.; Jimenez-Shahed, Joohi; Gross, Nicholas; Marinelli, Leslie; Wilhelm, Amanda; Gordon, Mark Forrest; Savola, Juha-Matti; Anderson, Karen E. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗